Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.760
+0.210 (4.62%)
At close: Sep 4, 2026, 4:00 PM EDT
4.759
-0.001 (-0.02%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Coya Therapeutics Market Cap
Coya Therapeutics has a market cap or net worth of $111.66 million as of September 4, 2026. Its market cap has decreased by -0.21% in one year.
Market Cap
111.66M
Enterprise Value
68.48M
1-Year Change
-0.21%
Ranking
Category
Stock Price
$4.76
ChartMarket Cap Chart
Since the IPO on December 29, 2022, Coya Therapeutics's market cap has increased from $11.84M to $111.66M, an increase of 843.26%. That is a compound annual growth rate of 83.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 111.66M | -8.00% |
| Dec 31, 2025 | 121.36M | 26.77% |
| Dec 31, 2024 | 95.73M | -10.29% |
| Dec 29, 2023 | 106.71M | 769.50% |
| Dec 30, 2022 | 12.27M | 3.68% |
| Dec 29, 2022 | 11.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aardvark Therapeutics | 117.74M |
| Connect Biopharma Holdings | 115.87M |
| Nautilus Biotechnology | 115.15M |
| ProMIS Neurosciences | 112.99M |
| Tenax Therapeutics | 111.13M |
| Fractyl Health | 110.88M |
| PolyPid | 109.48M |
| Genelux | 109.34M |